INDIES reports 6% increase in first quarter net profit
Trudiann Lowe2022-03-15T16:58:05-05:00March 15, 2022 Indies Pharma Jamaica Limited reported revenue of $212.30 million, 5% lower than the $223.53 million booked in 2021. Cost of Sales decreased 34% to close at $56.05 million (2021: $85.42 million). Gross profit increased by 13%, amounting to $156.25 million for the period relative to $138.11 million in 2021. Other operating income